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INTRODUCTION
lnflammatory rcsponses play a cen-
tlal role in a variety of allergic dis-
orders. These inllammatory rc-
sponses arc complex and may in-
volve seveml immunologic
pathways.'* It is now rccognized
that T-cells may influence a variely
of these pathways. The T-cell-de-
dved lymphokine, interleukin-2(IL2), plays a pivotal role in the
rcgulation of many T-cell mediated
responses and interacts with a high-
aflinity interleukin-2 receptor (IL
2R), which is expressed on a variety
ol cell types.r 6 Activation of
lymphoid cells is associated with se-
c.etion of IL2 and with the expres-
sion of high affinity IL-2R, which
are composed ofat least lrce chains(a, B, ,r) each interacting with dis-
tinct epilopes on the IL-2 molecule.
We hav€ prcviously reportedT thal
tle activation process is associated
with the release of one of these
chains, the Tac peptide or soluble
lL2R (SIL-2R). This soluble form
ofthe IL-2R is slighdy sma erthan
the cell-membrane-associated form
of the same molecule, and is fully
capable ofbinding IL2. Studies iD
a number of inflammatory diseases
including autoimmunity, AIDS,
and allograft reaction llave shown
tlat levels of soluble Tac protein in
serum and other sedetions correlate
with immunologic activation and
inflammation orocesses occurrine
in vivo.8 In th; present study w;
assessed IL-2R levels in the sera of
children with allergic disorders.
SUBJECT AND METHODS
Blood samples were obtained from
Iive groups: seven subjects aged l-
10 yeals with severe atopic eczema,
seven subjects aged 2-10 yeals with
mild atopic eczema, seven subjects
aged 5-10 yea6 with severe asthm4
seven subjects aged 4-8 years with
mild asthma, and seven omal sub-jects aged 1-13 years. Assignment
to mild or severe asthma was based
upon criteria rcported elsewhere."
Similarly, the scoring system pro-
posed by Sampson and Mccaskll'u
was applied to patients with eczema.
Those with a scorc =2+ were clas-
sified as aflected with mild eczema,
while children with a scorc of 3+/
4+ were grouped as affected with
sevele eczema.
Specific diagDoses werc estab-
lished on tle basis of family and
personal history, physical examina-
tion, and clinical follow-up. None
of the patients had been receiving
sleroids or other antiinflammatory
drugs over 2 months before blood
collection. lnfomed consenl was
obtained from childrcn's parents.
Blood Callection
Five milliliters of peripheral blood
was collected liom each patient and
promptly centrifuged for semm sep-
aration. Serum was either immedi-
ately processed for biochemical
evaluatiol or stored in small ali
quots (0.5 mL) at -70 'C until used.
bj a I uat i o n of I I E - m e d iat ed
hypersensitivity
For each patient, IgE-mediated hy-
persensjtjvity was evaluated by
prick-test, as well as by total(PRIST) and specific (RAST) ICE
serum content, These data were
then comparcd with results ofanaly-
sis of soluble IL-2R levels-
Assayingfor Soluble Tac Protein
Soluble Tac protein was measured
using a double epitope "sandwich-
enzyme-linked immunoassay," or
ELISA. This ELISA employs two
monoclonal antibodies binding at
distinct epitopes on the Tac protein.
The conversion ofsubstrate to p.od-
uct is proportional to the amount of
Tac protein present and the assay is
made quantitative by comparison to
a standard preparation of soluble
Tac prolein. The rcsults are ex-
pressed as (U/mL). Age-matched
normal control individuals were in-
cluded in the study. Linear reges-
sion test was used for statistical
analysis.
RESULTS
Shown in Figure 1 are the results of
IL-2R concentration detecte.d in
various groups of childrcn vrith al-
lergic disorders compared with nor-
md controls. There wiis considera-
ble overlap in the concentations of
soluble Tac protein between healthy
children, patients with mild asthma,
patients with mild eczema, patients
with severe asthma, aDd patients
with severe eczema (Fig 1). A1-
though serum Tac peptide concen-
trations were slightly el€vated in pa-
tients with severe eczema, no signif-
icant differences were obse ed
between tlis group and healthy con-
trols. Serum Tac concentrations
were not significantly correlated
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dete.mined by prick-skin testlng(Table 1).
DISCUSSION
Elevated serum concentmtions of
soluble Tac-peptide (ie, of the solu-
ble folm of the a-chain of IL2
receptor) have been demonstrated
in several conditions associated with
immune activation aDd/or dysre-
gulation, such as autoimmunity,
AIDS, and allogaft rejections and
systemic sclerosis.qlr It has been
postulated that abnormalities of the
immunoregulatory network may
play a rcle in the pathogenesis of
allergy.'l'3 lndeed, decreased num-
bers of CD3 and CD8 circulating T
lymphoc)-tes, and reduced in vito
suppressor cell activity have been
reponed in patients with aliergic dis-
On the basis of these data, we
have analyzed serum concentra-
tions ofsoluble IL2R in a cohort of
28 a ergic children with atopic-
eczema or asthma and seven age-
matched healthy contols. Serum
concenfatioDs of soluble lL-2R
were stgltly elevated in children
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Figure I . Serun levels of $luble interleukin 2 @eptor in childrea wirh alle€ic djsrdeE and
in age-marched controls.
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any ofthe goups under study (Fig in severe asthma: t: .145, P:
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Figu.e 2. Coftlarion between seron levels of soluble inierleukin-2 receplor and tolal lgE in chiltliet wilh altergic d'sorders- Lintu FSlssion
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Table L Corelalion of lL-28 Serum Levels and Skin Test Posilivity exception of patients witl severc
eczema.
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with severe eczema; however, t]re
dillerence was not statistrcally sig-
nificant as compared with healtly
controls,
lnterestingly, Matsumoto et al
have recendy rcported elevated
semm levels of soluble IL-2R in
children with eczema or food ana-
phylaxis.5'17 tn both the study of
Matsumoto et al and in the present
study, similar assays were employed
for measurement of serum concen-
trations of soluble IL-2R. Although
statistically significant results were
obtained only in the study of Mat-
sumoto et al, in boti studies an
overlap between s€rum concentra-
tions ofsoluble Tac protein in chil-
dren with eczema nd age-matched
controls was clearly observed. As-
sessment of serum Tac concentra-
tions is therefore of questionable
usefulness and significance for mon-
itodng alleryic inflammation in this
group of patients.
Contrcversial results have be€n
rcported on serum soluble IL2R
levels in patients with asthma.
Brown et al reported increased lev-
els in asthmatic subjects, independ-
ent of severity of the disease and of
the pres€nce of acute symptoms.l3
Cor.igan and Kay reported higher
serum levels of SIL2R and IFN
gamma in adults with acute
asthma.le In contrast, more re-
cently, Matsumoto et al have re-
ported that serum levels of SIL2R
arc not increased in children with
asthma. These apparent discrepan-
cies may reflect cellular release of
cltokine during i. vitro clotting
procedure, thus aflecting serum cy-
tokine levels. In order to avoid this
problem, we have imm€diately
processed each blood sample for
serum sepamtion.
Our rcsults on serum IL-2R levels
in asthmatic childrcn are in keeping
witl lhe obseflations by Matsu-
moto et al and support tle notion
that differences in the severity of
alleryic reactions do not appear to
rcsult in systemic amplification of
the immunologic adivation, as sug-
gested by the lack ofcorrelation of
soluble IL'2R concentrations in al-
lergic children with total IgE RAST
or pdck skin test positivity.
The rcsults of tie present study
are in agreement witi previous ob-
senations demonstrating that
serum IL-2R concentrations are
within the normal range in children
with bronchial asthma and ex-
tremely high total IgE levels.s Im-
mune activation mechanisms in-
votved in IgE synthesis and in the
produclion ofsoluble IL-2R appear
to be difTerent. Hawrylko et al have
recer1dy reported inoeased cellu]ar
pmduction of c)lokines during in-
flammatory processes.']o Thus, eval-
uation of cltokine production by
mononuclear cells might represent
a b€tter inflammatory index than
serum cltoKne levels.
ln conclusion, while it is possible
that abnormalities of other immu-
noregulatory pathways (including
IL-4, gamma-IFN, IgE-binding fac-
tor) are associated with allergy'?r 
"(and their measurement may t]lus
be useful in monitoring oftlese pa-
tients), our data suggest tlat evalu-
ation of serum soluble IL2R levels
is oflimited value in the assessment
ofallergic children, with the possible
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